June Chan, DSc

Title(s)Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th Street, #6146
San Francisco CA 94158
Phone415-514-4923
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeAB1994Applied Math in Biology
    Harvard School of Public HealthScD1998Epidemiology
    Harvard School of Public HealthPost-doctoral Fellowship2000 Epidemiology
    University of California, San Francisco, CA2020Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Dept. of Urology, UCSF2009Steven & Christine Burd-Safeway Distinguished Professorship
    American Association for Cancer Research & CA Dept. of Health Services2002  - 2003Early Career Investigator Award
    Prostate Cancer Foundation (formerly CaPCURE)1998  - 2000Young Investigator Award
    Society for Epidemiologic Research1998Abraham Lilienfeld Student Prize
    Harvard University1996  - 1997Pforzheimer Public Service Fellowship
    Uppsala University, Sweden1994  - 1995Fulbright Scholar

    Collapse Overview 
    Collapse Overview
    Dr. June M Chan leads novel research and advances education, with the common goals of improving patient care and public health outcomes.

    Dr. Chan has broad research interests in cancer prevention and public health, in particular what individuals can do to modify their risk of chronic disease, co-morbidity, and death. Her current research is focused on understanding how diet, exercise, other lifestyle factors and genetics contribute to prostate cancer progression, aggressiveness, and death. She is particularly interested in identifying modifiable lifestyle risk factors for prostate cancer progression, and using this information to better understand prostate cancer biology & inform public health recommendations. Her team's clinical and translational research studies aim to identify risk-reduction strategies for men with or at high risk for prostate cancer; evaluate novel molecular markers of prostate cancer aggressiveness that may improve screening, diagnosis, or prognosis of clinically relevant disease; and improve cancer survivorship for the millions of men living with prostate cancer worldwide. She has mentored over 40 students, post-docs, and faculty.

    She is PI of a randomized clinical trial examining an exercise intervention among men pursuing active surveillance for prostate cancer; co-PI on a large Dept. of Defense Translational Impact Award focused on improving risk stratification and decision support for men considering active surveillance for low risk prostate cancer; co-leads a national web-based intervention to promote healthy diet & exercise habits among men living with prostate cancer; serves on steering committee for a global clinical trial of exercise among men with metastatic prostate cancer; and is co-investigator on a trial examining a 2 year remotely monitored blended diet and exercise intervention for men undergoing surgery for prostate cancer. She also collaborates with team members on lifestyle interventions and observational research in bladder and colorectal cancer survivors. She and her team are currently launching a new digital cohort study of cancer survivors, called Eat Move Sleep, which is focused on enrolling under-represented individuals with prostate, bladder, or colorectal cancer.

    She developed the Diet & Lifestyle sub-study with the Cancer of the Prostate Strategic Research Endeavor (CaPSURE); and has collaborated broadly on other studies focused on prostate cancer, including the Health Professionals Follow-up Study, the Selenium and Vitamin E Cancer Prevention Trial (SELECT), the Prostate Cancer Active Surveillance Study (PASS), and the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group.

    Prior Training:
    1994 AB Applied Mathematics in Biology, Harvard College
    1994-95 Fulbright Scholar, Cancer Epidemiology Unit, Uppsala University, Sweden
    1998 ScD Epidemiology, Harvard School of Public Health

    Research Interest Keywords:
    - prostate cancer, cancer prevention, lifestyle risk factors, diet, physical activity, exercise, biomarkers, genetics, epidemiology, medical education, prognostication, public health, risk communication, health education & promotion

    Teaching
    - Course Director, Epid207 Epidemiologic Methods II, UCSF, Epidemiology & Biostatistics
    - Steering Committee Member, PhD Program in Epidemiology and Translational Science, UCSF

    - Previously (2007-2015) - Co-Director, Mechanisms, Methods, & Malignancy (M3), Essential Core Curriculum for Medical Students & Discipline Leader, Epidemiology and Evidence-Based Medicine, Essential Core Curriculum for Medical Students

    University Service
    - Vice Chair, Education, Epidemiology & Biostatistics UCSF
    - (previously, 2017-2021) Associate Chair, Clinical Research, Urology, UCSF
    - Executive Committee Member, Department of Epidemiology & Biostatistics, UCSF
    - Member, UCSF Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Leadership Committee
    Collapse Mentoring

    Collapse Research 
    Collapse Research Activities and Funding
    Short Courses on the Conduct of Reproducible Aging Research with Big Data
    NIH R25AG078149Aug 15, 2022 - Apr 30, 2027
    Role: Principal Investigator
    Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis
    NIH R01CA181802Apr 14, 2014 - Feb 28, 2021
    Role: Principal Investigator
    Prostate Microenvironmental &Prostate Cancer Progression
    NIH R01CA106947Sep 1, 2006 - Aug 31, 2011
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Collaboration Interests

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prostate-Specific Antigen Screening and Prostate Cancer Mortality: An Emulation of Target Trials in US Medicare. JCO Clin Cancer Inform. 2024 Aug; 8:e2400094. García-Albéniz X, Hsu J, Etzioni R, Chan JM, Shi J, Dickerman B, Hernán MA. PMID: 39159422.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    2. Cancer misinformation on social media. CA Cancer J Clin. 2024 Jun 19. Loeb S, Langford AT, Bragg MA, Sherman R, Chan JM. PMID: 38896503.
      View in: PubMed   Mentions:    Fields:    
    3. Plant-Based Diets and Disease Progression in Men With Prostate Cancer. JAMA Netw Open. 2024 May 01; 7(5):e249053. Liu VN, Van Blarigan EL, Zhang L, Graff RE, Loeb S, Langlais CS, Cowan JE, Carroll PR, Chan JM, Kenfield SA. PMID: 38691361; PMCID: PMC11063803.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Plant-based diet associated with better quality of life in prostate cancer survivors. Cancer. 2024 May 01; 130(9):1618-1628. Loeb S, Hua Q, Bauer SR, Kenfield SA, Morgans AK, Chan JM, Van Blarigan EL, Shreves AH, Mucci LA. PMID: 38348508; PMCID: PMC11009061.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer. 2024 May 15; 130(10):1766-1772. Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR. PMID: 38280206.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES). Res Involv Engagem. 2023 Dec 11; 9(1):117. Andemeskel G, Palmer NR, Pasick R, Van Blarigan EL, Kenfield SA, Graff RE, Shaw M, Yu W, Sanchez M, Hernandez R, Washington SL, Shariff-Marco S, Rhoads KF, Chan JM. PMID: 38082391; PMCID: PMC10712178.
      View in: PubMed   Mentions:
    7. Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial. Eur Urol Oncol. 2024 Jun; 7(3):519-526. Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM. PMID: 37907387.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Meeting Exercise Recommendations Is Beneficial for Cancer Survivors. J Clin Oncol. 2023 Nov 10; 41(32):4965-4967. Kenfield SA, Chan JM. PMID: 37729601.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature. 2023 Aug; 620(7976):1071-1079. Schroer AB, Ventura PB, Sucharov J, Misra R, Chui MKK, Bieri G, Horowitz AM, Smith LK, Encabo K, Tenggara I, Couthouis J, Gross JD, Chan JM, Luke A, Villeda SA. PMID: 37587343; PMCID: PMC10468395.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    10. Diabetes and incidence of breast cancer and its molecular subtypes: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2024 Jan; 40(1):e3709. Xiong F, Dai Q, Zhang S, Bent S, Tahir P, Van Blarigan EL, Kenfield SA, Chan JM, Schmajuk G, Graff RE. PMID: 37545374.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors. Am J Clin Nutr. 2023 09; 118(3):518-529. Kyaw TS, Upadhyay V, Tolstykh I, Van Loon K, Laffan A, Stanfield D, Gempis D, Kenfield SA, Chan JM, Piawah S, Atreya CE, Ng K, Venook A, Kidder W, Turnbaugh PJ, Van Blarigan EL. PMID: 37474105; PMCID: PMC10550847.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    12. Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies. Support Care Cancer. 2023 Jul 10; 31(8):453. Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA. PMID: 37428241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study. Br J Cancer. 2023 09; 129(4):648-655. Xiong F, Wang J, Nierenberg JL, Van Blarigan EL, Kenfield SA, Chan JM, Schmajuk G, Huang CY, Graff RE. PMID: 37402868; PMCID: PMC10421865.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study. JMIR Cancer. 2023 Jun 01; 9:e45432. Wang EY, Borno HT, Washington Iii SL, Friedlander T, Zhang S, Trejo E, Van Blarigan EL, Chan JM, Shariff-Marco S, Beatty AL, Kenfield SA. PMID: 37261885; PMCID: PMC10273032.
      View in: PubMed   Mentions:
    15. Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. Br J Cancer. 2023 08; 129(2):346-355. Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM. PMID: 37217583; PMCID: PMC10338438.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Nutrition Guidance for Patients on Androgen Deprivation Therapy. Eur Urol Focus. 2023 05; 9(3):427-430. Kenfield SA, Van Blarigan EL, Graff RE, Borno HT, Macaire G, Chan JM. PMID: 36935290.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages. Support Care Cancer. 2023 Feb 10; 31(3):155. Wang L, Langlais C, Kenfield SA, Van Loon K, Laffan A, Atreya CE, Chan JM, Zhang L, Allen IE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 36763183; PMCID: PMC9918568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II). Contemp Clin Trials. 2023 02; 125:107079. Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA. PMID: 36621597.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    19. Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention. Urol Oncol. 2023 03; 41(3):146.e1-146.e11. Langlais CS, Chen YH, Van Blarigan EL, Chan JM, Ryan CJ, Zhang L, Borno HT, Newton RU, Luke A, Bang AS, Panchal N, Tenggara I, Schultz B, Lavaki E, Pinto N, Aggarwal R, Friedlander T, Koshkin VS, Harzstark AL, Small EJ, Kenfield SA. PMID: 36528473.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Optimizing intervention tools to improve nutrition and physical activity for colorectal cancer survivors (Tools To Be Fit): Study protocol of a randomized factorial experiment. Contemp Clin Trials. 2022 12; 123:107009. Kenfield SA, Philip EJ, Phillips SM, Meyerhardt JA, Chan JM, Atreya CE, Kim MO, Harris Q, Steiding P, Macaire G, McCullough ML, Piawah S, Johnson WY, Kurttila FA, Lewis WL, Pesmen C, Watson Y, Van Blarigan EL. PMID: 36396066; PMCID: PMC10561599.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    21. Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort study. J Cancer Surviv. 2023 06; 17(3):836-847. Greenberg AL, Tolstykh IV, Van Loon K, Laffan A, Stanfield D, Steiding P, Kenfield SA, Chan JM, Atreya CE, Piawah S, Kidder W, Venook AP, Van Blarigan EL, Varma MG. PMID: 36335220; PMCID: PMC10209241.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. Eur J Epidemiol. 2022 Dec; 37(12):1205-1213. Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA. PMID: 36289138.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1760-1768. Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM. PMID: 35767977; PMCID: PMC9444922.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Post-diagnostic health behaviour scores in relation to fatal prostate cancer. Br J Cancer. 2022 11; 127(9):1670-1679. Graff RE, Langlais CS, Van Blarigan EL, Pernar CH, Stampfer MJ, Giovannucci EL, Mucci LA, Chan JM, Kenfield SA. PMID: 36028533; PMCID: PMC9596495.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. mHealth Interventions to Promote a Healthy Diet and Physical Activity among Cancer Survivors: A Systematic Review of Randomized Controlled Trials. Cancers (Basel). 2022 Aug 06; 14(15). Wang L, Langlais CS, Kenfield SA, Chan JM, Graff RE, Allen IE, Atreya CE, Van Blarigan EL. PMID: 35954479; PMCID: PMC9367623.
      View in: PubMed   Mentions: 11  
    26. Association of plant-based diet index with prostate cancer risk. Am J Clin Nutr. 2022 03 04; 115(3):662-670. Loeb S, Fu BC, Bauer SR, Pernar CH, Chan JM, Van Blarigan EL, Giovannucci EL, Kenfield SA, Mucci LA. PMID: 34791008; PMCID: PMC8895206.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    27. More evidence that physical activity is beneficial for prostate cancer. Prostate Cancer Prostatic Dis. 2022 09; 25(3):383-384. Kenfield SA, Chan JM. PMID: 35181745.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages. Support Care Cancer. 2022 May; 30(5):4557-4564. Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 35119520; PMCID: PMC8942969.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II). JMIR Cancer. 2022 Jan 11; 8(1):e31576. Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K. PMID: 35014958; PMCID: PMC8790683.
      View in: PubMed   Mentions: 6  
    30. Association between exposure to radioactive iodine after the Chernobyl accident and thyroid volume in Belarus 10-15 years later. Environ Health. 2022 01 07; 21(1):5. Chirikova E, McConnell RJ, O'Kane P, Yauseyenka V, Little MP, Minenko V, Drozdovitch V, Veyalkin I, Hatch M, Chan JM, Huang CY, Mabuchi K, Cahoon EK, Rozhko A, Zablotska LB. PMID: 34996456; PMCID: PMC8742457.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial. Integr Cancer Ther. 2022 Jan-Dec; 21:15347354211063500. Langlais CS, Chen YH, Van Blarigan EL, Kenfield SA, Kessler ER, Daniel K, Ramsdill JW, Beer TM, Graff RE, Paich K, Chan JM, Winters-Stone KM. PMID: 35389288; PMCID: PMC9016550.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. HGG Adv. 2022 Jan 13; 3(1). Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz LH, Loblaw A, Mamedov A, Goldenberg SL, Higano CS, Spillane M, Wu E, Carter HB, Pavlovich CP, Mamawala M, Landis T, Carroll PR, Chan JM, Cooperberg MR, Cowan JE, Morgan TM, Siddiqui J, Martin R, Klein EA, Brittain K, Gotwald P, Barocas DA, Dallmer JR, Gordetsky JB, Steele P, Kundu SD, Stockdale J, Roobol MJ, Venderbos LDF, Sanda MG, Arnold R, Patil D, Evans CP, Dall'Era MA, Vij A, Costello AJ, Chow K, Corcoran NM, Rais-Bahrami S, Phares C, Scherr DS, Flynn T, Karnes RJ, Koch M, Dhondt CR, Nelson JB, McBride D, Cookson MS, Stratton KL, Farriester S, Hemken E, Stadler WM, Pera T, Banionyte D, Bianco FJ, Lopez IH, Loeb S, Taneja SS, Byrne N, Amling CL, Martinez A, Boileau L, Gaylis FD, Petkewicz J, Kirwen N, Helfand BT, Xu J, Scholtens DM, Catalona WJ, Witte JS. PMID: 34993496; PMCID: PMC8725988.
      View in: PubMed   Mentions: 11     Fields:    
    33. Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer. Cancer Med. 2021 11; 10(22):8058-8070. Kenfield SA, Van Blarigan EL, Panchal N, Bang A, Zhang L, Graff RE, Chen YH, Ryan CJ, Luke A, Newton RU, Tenggara I, Schultz B, Wang E, Lavaki E, Zuniga K, Pinto N, Borno H, Aggarwal R, Friedlander T, Koshkin VS, Harzstark A, Small E, Chan JM. PMID: 34636156; PMCID: PMC8607248.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    34. Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort. J Urol. 2021 11; 206(5):1147-1156. Cooley LF, Emeka AA, Meyers TJ, Cooper PR, Lin DW, Finelli A, Eastham JA, Logothetis CJ, Marks LS, Vesprini D, Goldenberg SL, Higano CS, Pavlovich CP, Chan JM, Morgan TM, Klein EA, Barocas DA, Loeb S, Helfand BT, Scholtens DM, Witte JS, Catalona WJ, Collaborators. PMID: 34503355; PMCID: PMC8734323.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Reply by Authors. J Urol. 2021 11; 206(5):1156. Cooley LF, Emeka AA, Meyers TJ, Cooper PR, Lin DW, Finelli A, Eastham JA, Logothetis CJ, Marks LS, Vesprini D, Goldenberg SL, Higano CS, Pavlovich CP, Chan JM, Morgan TM, Klein EA, Barocas DA, Loeb S, Helfand BT, Scholtens DM, Witte JS, Catalona WJ. PMID: 34503354.
      View in: PubMed   Mentions:    Fields:    
    36. A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study. Urol Oncol. 2021 10; 39(10):730.e9-730.e15. Pollock Y, Zhang L, Kenfield SA, Van Blarigan EL, Rodvelt T, Rabow M, Macaire G, Weinberg R, Topp K, Friedlander T, Lin A, Fong L, Kim W, Ma B, Hough J, Lee M, Paciorek A, Ryan CJ, Chan JM, Small E, Aggarwal R. PMID: 34304981.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    37. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing. JCO Precis Oncol. 2021; 5. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Kageyama R, Wells DK, Chan JM, Friedlander T, Aggarwal R, Paris PL, Feng F, Carroll PR, Witte JS. PMID: 34250416; PMCID: PMC8232833.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes Control. 2021 Jun; 32(6):635-644. Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL. PMID: 33837499; PMCID: PMC8189293.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter. J Urol. 2021 07; 206(1):171-172. Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ. PMID: 33818133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality. Curr Oncol Rep. 2021 03 10; 23(3):37. Langlais CS, Graff RE, Van Blarigan EL, Palmer NR, Washington SL, Chan JM, Kenfield SA. PMID: 33689041; PMCID: PMC7946660.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    41. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer. Sci Rep. 2021 03 03; 11(1):5040. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Chu C, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Chan JM, Friedlander T, Wyatt AW, Aggarwal R, Paris PL, Carroll PR, Feng F, Witte JS. PMID: 33658587; PMCID: PMC7930042.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    42. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 12 31; 22(12):e19238. Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. PMID: 33382378; PMCID: PMC7808895.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    43. Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study. JMIR Cancer. 2020 Nov 10; 6(2):e19362. Wang EY, Graff RE, Chan JM, Langlais CS, Broering JM, Ramsdill JW, Kessler ER, Winters-Stone KM, Van Blarigan EL, Kenfield SA. PMID: 33170126; PMCID: PMC7685923.
      View in: PubMed   Mentions: 6  
    44. Opportunities and challenges for research on low-carbohydrate diets in prostate cancer. Nat Rev Urol. 2020 08; 17(8):437-438. Langlais CS, Chan JM. PMID: 32358563.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer. J Racial Ethn Health Disparities. 2020 10; 7(5):996-1002. Zuniga KB, Borno H, Chan JM, Van Blarigan EL, Friedlander TW, Wang S, Zhang L, Kenfield SA. PMID: 32078741; PMCID: PMC8567804.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):752-760. Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP. PMID: 31941707; PMCID: PMC7125029.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    47. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 01; 9(1):125-132. Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. PMID: 31714037; PMCID: PMC6943165.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    48. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 10; 202(4):689-695. Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. PMID: 31091175; PMCID: PMC7017721.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    49. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol. 2019 10; 202(4):702-709. Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR. PMID: 31026214.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    50. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2019 10; 202(4):696-701. Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR. PMID: 30958742.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1917-1925. Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. PMID: 31462398; PMCID: PMC6825577.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    52. Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance. Prostate Cancer Prostatic Dis. 2020 03; 23(1):136-143. Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR. PMID: 31455846; PMCID: PMC8076042.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    53. Diet and lifestyle considerations for patients with prostate cancer. Urol Oncol. 2020 03; 38(3):105-117. Zuniga KB, Chan JM, Ryan CJ, Kenfield SA. PMID: 31327752; PMCID: PMC7293879.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    54. Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study. J Clin Oncol. 2019 06 10; 37(17):1499-1511. Downer MK, Kenfield SA, Stampfer MJ, Wilson KM, Dickerman BA, Giovannucci EL, Rimm EB, Wang M, Mucci LA, Willett WC, Chan JM, Van Blarigan EL. PMID: 31026211; PMCID: PMC6599404.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    55. The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies. Int J Cancer. 2019 12 15; 145(12):3244-3256. Watts EL, Perez-Cornago A, Appleby PN, Albanes D, Ardanaz E, Black A, Bueno-de-Mesquita HB, Chan JM, Chen C, Chubb SAP, Cook MB, Deschasaux M, Donovan JL, English DR, Flicker L, Freedman ND, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Häggström C, Haiman C, Hamdy FC, Hercberg S, Holly JM, Huang J, Huang WY, Johansson M, Kaaks R, Kubo T, Lane JA, Layne TM, Le Marchand L, Martin RM, Metter EJ, Mikami K, Milne RL, Morris HA, Mucci LA, Neal DE, Neuhouser ML, Oliver SE, Overvad K, Ozasa K, Pala V, Pernar CH, Pollak M, Rowlands MA, Schaefer CA, Schenk JM, Stattin P, Tamakoshi A, Thysell E, Touvier M, Trichopoulou A, Tsilidis KK, Van Den Eeden SK, Weinstein SJ, Wilkens L, Yeap BB, Key TJ, Allen NE, Travis RC. PMID: 30873591; PMCID: PMC6745281.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    56. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218. Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP. PMID: 30866859; PMCID: PMC6417122.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    57. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target. J Natl Cancer Inst. 2019 03 01; 111(3):301-310. Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY. PMID: 30321406.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    58. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2019 02; 201(2):300-307. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. PMID: 30179620.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    59. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019 06; 75(6):950-958. Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. PMID: 30638635.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    60. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437. Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA, Transdisciplinary Prostate Cancer Partnership (ToPCaP). PMID: 30165429; PMCID: PMC6314328.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    61. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15; 7(11):e11257. Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. PMID: 30442638; PMCID: PMC6265599.
      View in: PubMed   Mentions: 5  
    62. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk. Cancer Res. 2019 01 01; 79(1):274-285. Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, Rissanen H, Yeap BB, Flicker L, Almeida OP, Wong YYE, Chan JM, Giovannucci EL, Stampfer MJ, Ursin G, Gislefoss RE, Bjørge T, Meyer HE, Blomhoff R, Tsugane S, Sawada N, English DR, Eyles DW, Heath AK, Williamson EJ, Manjer J, Malm J, Almquist M, Marchand LL, Haiman CA, Wilkens LR, Schenk JM, Tangen CM, Black A, Cook MB, Huang WY, Ziegler RG, Martin RM, Hamdy FC, Donovan JL, Neal DE, Touvier M, Hercberg S, Galan P, Deschasaux M, Key TJ, Allen NE. PMID: 30425058; PMCID: PMC6330070.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    63. Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies. Eur Urol. 2018 11; 74(5):585-594. Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, Ozasa K, Platz EA, Quirós JR, Rissanen H, Sawada N, Stampfer M, Stanczyk FZ, Stattin P, Tamakoshi A, Tangen CM, Thompson IM, Tsilidis KK, Tsugane S, Ursin G, Vatten L, Weiss NS, Yeap BB, Allen NE, Key TJ, Travis RC. PMID: 30077399; PMCID: PMC6195673.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    64. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study. Eur Urol Oncol. 2019 03; 2(2):126-134. Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ. PMID: 31017087.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    65. Association of Statin Use With Overall and Cancer Survival. JAMA Oncol. 2018 07 01; 4(7):1016. Chan JM, Kenfield SA, Platz EA. PMID: 29800037.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer. Eur Urol. 2018 10; 74(4):444-452. Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E, Carroll PR. PMID: 29853306; PMCID: PMC6586429.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    67. Increasing Physical Activity in Mothers Using Video Exercise Groups and Exercise Mobile Apps: Randomized Controlled Trial. J Med Internet Res. 2018 05 18; 20(5):e179. Mascarenhas MN, Chan JM, Vittinghoff E, Van Blarigan EL, Hecht F. PMID: 29776899; PMCID: PMC5984277.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    68. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open. 2018 05 14; 8(5):e022899. Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, Finn SP, Greenwood R, Hughes DC, Mucci L, Plymate SR, Praet SFE, Guinan EM, Van Blarigan EL, Casey O, Buzza M, Gledhill S, Zhang L, Galvão DA, Ryan CJ, Saad F. PMID: 29764892; PMCID: PMC5961562.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    69. Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. PLoS One. 2017; 12(12):e0187741. Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC. PMID: 29281666; PMCID: PMC5744924.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    70. Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study. Prostate. 2018 02; 78(3):202-212. Bauer SR, Van Blarigan EL, Stampfer MJ, Chan JM, Kenfield SA. PMID: 29194691; PMCID: PMC5768457.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan; 78(1):32-39. Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. PMID: 29105845; PMCID: PMC5716878.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    72. Epidemiology of prostate cancer. World J Urol. 2017 06; 35(6):849. Cooperberg MR, Chan JM. PMID: 28509969.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    73. The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer. 2017 Apr 18; 3(1):e5. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM. PMID: 28420602; PMCID: PMC5413797.
      View in: PubMed   Mentions: 16  
    74. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2017 03; 77(4):425-434. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP. PMID: 27900799; PMCID: PMC5479703.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    75. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017 Jun; 35(6):867-874. Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. PMID: 27518576; PMCID: PMC5472048.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    76. Trends in Biometric Health Indices Within an Employer-Sponsored Wellness Program With Outcome-Based Incentives. Am J Health Promot. 2016 07; 30(6):453-7. Fu PL, Bradley KL, Viswanathan S, Chan JM, Stampfer M. PMID: 27445326.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT. Cancer Epidemiol Biomarkers Prev. 2016 07; 25(7):1050-1058. Chan JM, Darke AK, Penney KL, Tangen CM, Goodman PJ, Lee GM, Sun T, Peisch S, Tinianow AM, Rae JM, Klein EA, Thompson IM, Kantoff PW, Mucci LA. PMID: 27197287; PMCID: PMC5086806.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    78. Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn. 2016 05; 18(3):395-406. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP. PMID: 26945428; PMCID: PMC4851733.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    79. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016 04 15; 76(8):2288-2300. Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak M, Price AJ, Roobol MJ, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Ziegler RG, Key TJ, Allen NE. PMID: 26921328; PMCID: PMC4873385.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    80. Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score. Urology. 2016 Mar; 89:69-75. Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ. PMID: 26723180.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    81. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. PMID: 26585352; PMCID: PMC5493324.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    82. Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer. J Natl Cancer Inst. 2016 Mar; 108(3). Kenfield SA, Batista JL, Jahn JL, Downer MK, Van Blarigan EL, Sesso HD, Giovannucci EL, Stampfer MJ, Chan JM. PMID: 26577654; PMCID: PMC5964905.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    83. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 05; 163(4):1011-25. Cancer Genome Atlas Research Network. PMID: 26544944; PMCID: PMC4695400.
      View in: PubMed   Mentions: 1501     Fields:    Translation:HumansCells
    84. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015 Nov; 102(5):1142-57. Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, Goodman PJ, Gunter MJ, Hamdy FC, Heliövaara M, Helzlsouer KJ, Henderson BE, Hercberg S, Hoffman-Bolton J, Hoover RN, Johansson M, Khaw KT, King IB, Knekt P, Kolonel LN, Le Marchand L, Männistö S, Martin RM, Meyer HE, Mondul AM, Moy KA, Neal DE, Neuhouser ML, Palli D, Platz EA, Pouchieu C, Rissanen H, Schenk JM, Severi G, Stampfer MJ, Tjønneland A, Touvier M, Trichopoulou A, Weinstein SJ, Ziegler RG, Zhou CK, Allen NE, Endogenous Hormones Nutritional Biomarkers Prostate Cancer Collaborative Group. PMID: 26447150; PMCID: PMC4625592.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    85. Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study. Cancer Prev Res (Phila). 2015 Oct; 8(10):962-967. Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW, Clinton SK, Chan JM, Mucci LA. PMID: 26276753; PMCID: PMC4596787.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    86. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1638-40. Chan JM, Kenfield SA, Paciorek A, Platz EA, Giovannucci EL, Stampfer MJ. PMID: 26189767; PMCID: PMC4735873.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    87. Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study. Cancer Causes Control. 2015 Aug; 26(8):1117-26. Van Blarigan EL, Kenfield SA, Yang M, Sesso HD, Ma J, Stampfer MJ, Chan JM, Chavarro JE. PMID: 26047644; PMCID: PMC4499006.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    88. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    89. Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study. J Cancer Surviv. 2015 Sep; 9(3):500-11. Phillips SM, Stampfer MJ, Chan JM, Giovannucci EL, Kenfield SA. PMID: 25876555; PMCID: PMC4537833.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    90. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015 May; 51(7):817-24. Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA. PMID: 25794605; PMCID: PMC4402138.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    91. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet. 2015 Apr; 134(4):439-50. Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Fontham ET, Smith G, Mohler JL, Berndt SI, McDonnell SK, Kittles R, Rybicki BA, Freedman M, Kantoff PW, Pomerantz M, Breyer JP, Smith JR, Rebbeck TR, Mercola D, Isaacs WB, Wiklund F, Cussenot O, Thibodeau SN, Schaid DJ, Cannon-Albright L, Cooney KA, Chanock SJ, Stanford JL, Chan JM, Witte J, Xu J, Bensen JT, Taylor JA, Catalona WJ. PMID: 25715684; PMCID: PMC4586077.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    92. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis. Clin Genitourin Cancer. 2015 Aug; 13(4):370-377.e1. Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA. PMID: 25662905; PMCID: PMC5038132.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    93. Hair, hormones, and high-risk prostate cancer. J Clin Oncol. 2015 Feb 10; 33(5):386-7. Ryan CJ, Chan JM. PMID: 25547509.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2015 Jan; 107(1):360. Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan JM. PMID: 25505227; PMCID: PMC4296194.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    95. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM. PMID: 25284284; PMCID: PMC4257852.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    96. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    97. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015 Oct; 68(4):600-8. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. PMID: 25242555.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    98. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. PMID: 24836057.
      View in: PubMed   Mentions: 271     Fields:    Translation:HumansCells
    99. What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol. 2014 May; 24(3):318-23. Chan JM, Van Blarigan EL, Kenfield SA. PMID: 24625429; PMCID: PMC4084902.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    100. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):1037-46. Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, Giovannucci EL, Witte JS, Erdman JW, Chan JM, Penney KL. PMID: 24711484; PMCID: PMC4047147.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    101. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int. 2014 Dec; 114(6b):E18-E24. Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR. PMID: 24712895.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    102. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 24504435; PMCID: PMC3990413.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    103. Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. Eur Urol. 2014 May; 65(5):852-5. Jones LW, Hornsby WE, Freedland SJ, Lane A, West MJ, Moul JW, Ferrandino MN, Allen JD, Kenjale AA, Thomas SM, Herndon JE, Koontz BF, Chan JM, Khouri MG, Douglas PS, Eves ND. PMID: 24315706; PMCID: PMC4089506.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    104. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM. PMID: 24095905; PMCID: PMC5480381.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    105. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-1120. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. PMID: 24051140.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    106. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. PMID: 24035632.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    107. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM. PMID: 24038157; PMCID: PMC5501162.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    108. Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study. Eur Urol. 2014 May; 65(5):887-94. Kenfield SA, DuPre N, Richman EL, Stampfer MJ, Chan JM, Giovannucci EL. PMID: 23962747; PMCID: PMC4157361.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    109. Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med. 2013 Jul 22; 173(14):1318-26. Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, Willett WC, Chan JM. PMID: 23752662; PMCID: PMC3935610.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    110. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR. PMID: 23318528.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    111. Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Nutr Cancer. 2013; 65(1):157-64. Chan JM, Gong Z, Holly EA, Bracci PM. PMID: 23368926; PMCID: PMC4465200.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    112. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol. 2013 Jan; 20(1):39-44. Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. PMID: 23232570; PMCID: PMC3535290.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    113. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (Phila). 2012 Oct; 5(10):1223-8. Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. PMID: 22961777; PMCID: PMC3526345.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    114. Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr. 2012 Oct; 96(4):855-63. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan JM. PMID: 22952174; PMCID: PMC3441112.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    115. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 01; 30(28):3540-4. Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL. PMID: 22927523; PMCID: PMC3454771.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    116. Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1886-8. Chan JM, Litwack-Harrison S, Bauer SR, Daniels NA, Wilt TJ, Shannon J, Bauer DC. PMID: 22879205; PMCID: PMC3489270.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    117. Editorial comment. Urology. 2012 Aug; 80(2):305-6. Cooperberg MR, Chan JM. PMID: 22749427.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    118. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):211. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM. PMID: 22588589.
      View in: PubMed   Mentions:
    119. Selenium and prostate cancer: the puzzle isn't finished yet. Am J Clin Nutr. 2012 Jul; 96(1):1-2. Richman EL, Chan JM. PMID: 22623750; PMCID: PMC3374730.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    120. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. PMID: 22553345.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    121. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):428-36. Pettersson A, Kasperzyk JL, Kenfield SA, Richman EL, Chan JM, Willett WC, Stampfer MJ, Mucci LA, Giovannucci EL. PMID: 22315365; PMCID: PMC3297731.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimals
    122. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):189-94. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM. PMID: 22343837.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    123. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011 Dec; 4(12):2110-21. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. PMID: 21930800; PMCID: PMC3232297.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    124. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659; PMCID: PMC3164676.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    125. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012 Jul 01; 131(1):201-10. Richman EL, Carroll PR, Chan JM. PMID: 21823116; PMCID: PMC3310254.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    126. Smoking and prostate cancer survival and recurrence. JAMA. 2011 Jun 22; 305(24):2548-55. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. PMID: 21693743; PMCID: PMC3562349.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    127. Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? Urol Oncol. 2013 Jul; 31(5):522-30. Aggarwal RR, Ryan CJ, Chan JM. PMID: 21658978.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    128. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 01; 71(11):3889-95. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. PMID: 21610110; PMCID: PMC3107352.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    129. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011 Feb 20; 29(6):726-32. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. PMID: 21205749; PMCID: PMC3056656.
      View in: PubMed   Mentions: 241     Fields:    Translation:Humans
    130. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int. 2011 Jan; 107(1):126-34. Abe M, Xie W, Regan MM, King IB, Stampfer MJ, Kantoff PW, Oh WK, Chan JM. PMID: 20477822; PMCID: PMC3010266.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    131. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. PMID: 21103921; PMCID: PMC3002170.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    132. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer. 2010 Oct 15; 127(8):1893-904. Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. PMID: 20104522; PMCID: PMC2930138.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    133. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int. 2010 Sep; 106(5):627-32. Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV. PMID: 20151961.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    134. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. 2012 Mar-Apr; 30(2):155-60. Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM. PMID: 20800514.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    135. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 01; 116(9):2140-7. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS. PMID: 20309846; PMCID: PMC2893877.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    136. Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes Control. 2010 Aug; 21(8):1297-303. Barnett CM, Nielson CM, Shannon J, Chan JM, Shikany JM, Bauer DC, Hoffman AR, Barrett-Connor E, Orwoll E, Beer TM. PMID: 20383574; PMCID: PMC2903686.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    137. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. PMID: 20042525; PMCID: PMC3132069.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    138. Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. J Clin Oncol. 2009 Oct 20; 27(30):4980-5. Shappley WV, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan JM. PMID: 19720918; PMCID: PMC2799054.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    139. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol. 2009 Aug 01; 27(22):3577-83. Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW. PMID: 19528373; PMCID: PMC2720077.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    140. Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control. 2009 Aug; 20(6):835-46. Chan JM, Wang F, Holly EA. PMID: 19277880; PMCID: PMC2694313.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    141. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med. 2009 Feb 23; 169(4):351-6. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. PMID: 19237718; PMCID: PMC2881689.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    142. The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):148-54. Farhat GN, Taioli E, Cauley JA, Zmuda JM, Orwoll E, Bauer DC, Wilt TJ, Hoffman AR, Beer TM, Shikany JM, Daniels N, Chan J, Fink HA, Barrett-Connor E, Parsons JK, Bunker CH, Osteoporotic Fractures in Men (MrOS) Study Group. PMID: 19124492; PMCID: PMC2651680.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    143. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med. 2008 Oct 07; 149(7):461-71, W83-8. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schröder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P. PMID: 18838726; PMCID: PMC2584869.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    144. No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. Prostate. 2008 Sep 15; 68(13):1416-20. Fall K, Stark JR, Mucci LA, Chan J, Stampfer MJ, Kurth T, Febbo PG, Kantoff P, Ma J. PMID: 18615538; PMCID: PMC2958090.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    145. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008 Apr 15; 112(8):1650-9. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR. PMID: 18306379.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansPHPublic Health
    146. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 2008 Feb 06; 100(3):170-83. Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ. PMID: 18230794; PMCID: PMC6126902.
      View in: PubMed   Mentions: 230     Fields:    Translation:Humans
    147. Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California. Am J Epidemiol. 2007 Nov 15; 166(10):1174-85. Chan JM, Wang F, Holly EA. PMID: 17881383.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    148. Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California. Cancer Causes Control. 2007 Dec; 18(10):1153-67. Chan JM, Wang F, Holly EA. PMID: 17805983.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    149. Development of a meat frequency questionnaire for use in diet and cancer studies. J Am Diet Assoc. 2007 Aug; 107(8):1356-62. Keating GA, Bogen KT, Chan JM. PMID: 17659903.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    150. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol. 2007 Jun; 8(3):173-96. Kenfield SA, Chang ST, Chan JM. PMID: 17763836.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    151. Prostate cancer. J Urol. 2007 Jun; 177(6):2020-9. Penson DF, Chan JM, Urologic Diseases in America Project. PMID: 17509282.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    152. Demographic factors associated with the diet quality of older US men: baseline data from the Osteoporotic Fractures in Men (MrOS) study. Public Health Nutr. 2007 Aug; 10(8):810-8. Shannon J, Shikany JM, Barrett-Connor E, Marshall LM, Bunker CH, Chan JM, Stone KL, Orwoll E, Osteoporotic Fractures in Men (MrOS) Research Group. PMID: 17381915.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    153. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Urol Oncol. 2007 Mar-Apr; 25(2):134-40. Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID. PMID: 17349528.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    154. Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans. Prostate Cancer Prostatic Dis. 2007; 10(3):261-9. Bogen KT, Keating GA, Chan JM, Paine LJ, Simms EL, Nelson DO, Holly EA. PMID: 17224912.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    155. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17141841.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    156. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. Hematol Oncol Clin North Am. 2006 Aug; 20(4):797-809. Chan JM, Feraco A, Shuman M, Hernández-Díaz S. PMID: 16861115.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    157. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006 Mar; 17(2):199-208. Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Giovannucci EL. PMID: 16425098.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    158. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. PMID: 16360447.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    159. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005 Nov 10; 23(32):8152-60. Chan JM, Gann PH, Giovannucci EL. PMID: 16278466.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    160. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. PMID: 16286124.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    161. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control. 2005 Sep; 16(7):789-97. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR. PMID: 16132789.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    162. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005 Sep; 14(9):2093-7. Chan JM, Wang F, Holly EA. PMID: 16172215.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimals
    163. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ. PMID: 15758721.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    164. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 2005 Aug; 26(8):1368-73. Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. PMID: 15802297.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    165. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. PMID: 15711258.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    166. Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer. Clin Prostate Cancer. 2005 Mar; 3(4):239-45. Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan JM. PMID: 15882480.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. Chan JM, Jou RM, Carroll PR. PMID: 15535436.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    168. Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. J Urol. 2004 Nov; 172(5 Pt 2):S3-5. Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW. PMID: 15535434.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    169. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):759-64. Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J. PMID: 15159307.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    170. A prospective study on supplemental vitamin e intake and risk of colon cancer in women and men. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1298-304. Wu K, Willett WC, Chan JM, Fuchs CS, Colditz GA, Rimm EB, Giovannucci EL. PMID: 12433706.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    171. Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1108-11. Leitzmann MF, Stampfer MJ, Ma J, Chan JM, Colditz GA, Willett WC, Giovannucci E. PMID: 12376516.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    172. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1099-106. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E. PMID: 12122101.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    173. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001 Oct; 74(4):549-54. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. PMID: 11566656.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    174. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst. 2001 Sep 05; 93(17):1330-6. Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ. PMID: 11535708.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimals
    175. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev. 2001; 23(1):82-6. Chan JM, Giovannucci EL. PMID: 11588858.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    176. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev. 2001; 23(1):87-92. Chan JM, Giovannucci EL. PMID: 11588859.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    177. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control. 2000 Oct; 11(9):859-67. Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J. PMID: 11075876.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    178. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S32-3. Chan JM, Stampfer MJ, Giovannucci E, Ma J, Pollak M. PMID: 10984284.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    179. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S28-9. Ma J, Pollak M, Giovannucci E, Chan JM, Tao Y, Hennekens C, Stampfer MJ. PMID: 10984282.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    180. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999 Oct; 8(10):893-9. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. PMID: 10548318.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    181. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999 Apr 07; 91(7):620-5. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. PMID: 10203281.
      View in: PubMed   Mentions: 279     Fields:    Translation:Humans
    182. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999 Jan; 42(1):107-12. Lindblad P, Chow WH, Chan J, Bergström A, Wolk A, Gridley G, McLaughlin JK, Nyrén O, Adami HO. PMID: 10027588.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    183. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) Cancer Causes Control. 1998 Dec; 9(6):559-66. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A. PMID: 10189041.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    184. What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol. 1998 Aug; 8(4):263-73. Chan JM, Stampfer MJ, Giovannucci EL. PMID: 9870033.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    185. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998 Jan 23; 279(5350):563-6. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. PMID: 9438850.
      View in: PubMed   Mentions: 410     Fields:    Translation:Humans
    186. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995 Mar 04; 310(6979):555-9. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. PMID: 7888928; PMCID: PMC2548937.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    187. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994 Sep; 17(9):961-9. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. PMID: 7988316.
      View in: PubMed   Mentions: 422     Fields:    Translation:Humans
    June's Networks
    Concepts (457)
    Derived automatically from this person's publications.
    _
    Co-Authors (99)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _